SynthesisEuropean journal of nuclear medicine and molecular imaging2020

Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice.

Sabina Dizdarevic et al.PubMed ↗Publisher ↗

No numbers read from the abstract.